[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351323-105":59,"doc-detail-351323-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-activated-pathways-in-doxorubicin-resistant-tnbc-alters-signaling-survival-and-emt-a-double-edged-sword","Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword","","Triple-negative breast cancer (TNBC) remains difficult to treat because targeted options are limited and resistance to chemotherapy develops, including to doxorubicin (DOX). This study evaluated how inhibiting activated pathways in DOX-resistant TNBC affects MAPK and PI3K/Akt signaling, cell-cycle regulation, and EMT regulators. Continuous DOX exposure selected EMT-like resistant cells. Western blotting and qPCR assessed death, survival, mitophagy, and EMT markers, alongside migration differences under inhibitor treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-activated-pathways-in-doxorubicin-resistant-tnbc-alters-signaling-survival-and-emt-a-double-edged-sword/351323/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-activated-pathways-in-doxorubicin-resistant-tnbc-alters-signaling-survival-and-emt-a-double-edged-sword/351323.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study on DOX-resistant TNBC?","Question",{"text":112,"@type":113},"To investigate how inhibiting activated pathways in DOX-resistant TNBC affects MAPK and PI3K/Akt signaling, cell-cycle regulation, and EMT regulators.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were resistant TNBC cells generated and characterized?",{"text":117,"@type":113},"Cells were continuously exposed to increasing DOX concentrations to select resistant cells with EMT characteristics, then EMT-, survival-, and death-related markers were measured by Western blotting and qPCR.",{"name":119,"@type":110,"acceptedAnswer":120},"Which inhibitor pathway showed stronger effects on signaling shutdown?",{"text":121,"@type":113},"MEK inhibition was less effective than PI3K inhibition in both sensitive and resistant cells, while the combined MEK and PI3K inhibitors suppressed these signals more effectively.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351323,1790620300,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nTargeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword  \nIrem Dogan Turacli 1,2, *, Sahika Cingir Koker 1,2, Kubra Paspal Eroglu 1,2 and Banu Yalcin 2  \nAcademic Editor: Christos Papadimitriou  \nReceived: 24 January 2026  \nRevised: 9 March 2026  \nAccepted: 13 March 2026  \nPublished: 19 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Faculty of Medicine, Department of Medical Biology, Ufuk University, Ankara 06520, Turkey; [sahika.koker@gmail.com](sahika.koker@gmail.com) (S.C.K.); [kubra.paspal.eroglu@gmail.com](kubra.paspal.eroglu@gmail.com) (K.P.E.)  \n2 Ogretmen Naime Tomek Research Laboratory (ONTAL), Faculty of Medicine, Ufuk University, Ankara 06520, Turkey; [banuyalcnn@gmail.com](banuyalcnn@gmail.com)  \n* Correspondence: [doganirem@gmail.com](doganirem@gmail.com)  \nAbstract  \nTriple-negative breast cancer (TNBC) poses significant therapeutic challenges due to the limited availability of targeted treatment options and the development of resistance to chemotherapy, including doxorubicin (DOX) . The objective of this study was to investigate the impact of inhibiting activated pathways in DOX-resistant TNBC and examine the effects on MAPK and PI3K/Akt signaling pathways, cell cycle regulation, and the regulators of the epithelial–mesenchymal transition (EMT) process. Continuous exposure of cells to increasing concentrations of DOX resulted in the selection of resistant cells that exhibited EMT characteristics. We assessed the expression levels of markers related to cell death, survival, mitophagy pathways and EMT using Western blotting and qPCR in both sensitive and resistant cells with activated-pathway inhibitor treatments. Additionally, we demonstrated differences in migration capacity between resistant and sensitive cells with or without inhibitor treatments. It was found that MEK inhibition was less effective than PI3K inhibition in both sensitive and resistant cells. Expression analyses clearly demonstrated that resistant cells exhibited more aggressive behavior, as indicated by EMTand survival-related gene expressions. The combination of MEK and PI3K inhibitors was more effective in shutting down these signals in both cell types. The ability to induce EMTin DOX-resistant cells revealed that one form of resistance might combine with another, acting as a mediator for cellular switch. Although drug resistance and various inhibitors reduce the proliferative capacity of cells and related parameters, resistance contributes to the acquisition of metastatic characteristics.  \nKeywords: TNBC; doxorubicin; MEK; PI3K; EMT  \n1. Introduction  \nBreast cancer (BC) is the most common type of cancer in women worldwide. It is genetically and clinically heterogeneous and primarily classified into two subgroups: ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS) . Histopathological type, tumor stage, and molecular markers such as Estrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal Receptor 2 (HER2) are used for both the classification of breast cancer and the development of treatment strategies [1] . Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, characterized by the lack of expression of ER, PR and HER-2 [2] . The aggressive nature of TNBC is attributed to its heterogeneity, its capacity for rapid metastasizing to the brain, lungs, and bones, and its rapid  \nonset of recurrence. These characteristics challenge the treatment for TNBC [3] . Due to the absence of hormone receptor expressions in TNBC, it precludes the possibility of endocrine therapy, thus rendering chemotherapy and radiotherapy as the main therapeutic options for TNBC [4] . Lately, immune checkpoint inhibitors (ICI) have been investigated but the efficacy of ","cbCaifNeHS0rqVLh","https://ap.wps.com/l/cbCaifNeHS0rqVLh","pdf",6390654,16,"English","# Abstract\n# Introduction","[{\"question\":\"What was the main objective of the study on DOX-resistant TNBC?\",\"answer\":\"To investigate how inhibiting activated pathways in DOX-resistant TNBC affects MAPK and PI3K/Akt signaling, cell-cycle regulation, and EMT regulators.\"},{\"question\":\"How were resistant TNBC cells generated and characterized?\",\"answer\":\"Cells were continuously exposed to increasing DOX concentrations to select resistant cells with EMT characteristics, then EMT-, survival-, and death-related markers were measured by Western blotting and qPCR.\"},{\"question\":\"Which inhibitor pathway showed stronger effects on signaling shutdown?\",\"answer\":\"MEK inhibition was less effective than PI3K inhibition in both sensitive and resistant cells, while the combined MEK and PI3K inhibitors suppressed these signals more effectively.\"}]","Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword | PDF",1790093564,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/651952741b9a96756b3c86f7a415b0d9.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/adb9cc08f7ff87aa8908e5502096328c.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/563bc29b0207db09cf213ef563f0abc7.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae509c942134e94d4ed469b4a42cfa66.webp",980,1385]